Novel PET molecular imaging agent (investigational for renal cell carcinoma)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Novel PET molecular imaging agent (investigational for renal cell carcinoma), covering 2025-12-24 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma [NA]